Cigna Group 10-Q quarterly reports

The Cigna Group reported a 7% increase in total revenues to $71.7 billion for the second quarter of 2026, with net income rising 15% to $1.875 billion.

The Cigna Group reported a 5% increase in total revenues for the first quarter of 2026, driven by strong performance in its Evernorth Health Services segment.

The Cigna Group reported a significant increase in Q3 2025 shareholders' net income, driven by robust pharmacy revenues and the absence of prior year's equity impairment.

The Cigna Group announced an 11% increase in total revenues for the second quarter of 2025, reaching $67.18 billion, alongside a 5% rise in diluted earnings per share, despite a significant decline in operating cash flow.

The Cigna Group's Q1 2025 results show increased revenues and net income, driven by pharmacy and premium growth, and the completion of the Medicare Advantage divestiture to HCSC.

The Cigna Group's third-quarter results show a decrease in net income, impacted by a significant investment impairment, while adjusted income from operations saw a modest increase.

The Cigna Group's second-quarter results show a revenue increase but a significant drop in net income due to an investment impairment, alongside progress in strategic divestitures.

The Cigna Group reported a net loss for the first quarter of 2024, primarily due to a significant impairment of equity securities, despite a rise in adjusted revenues and operating income.